| | Report | Presentation | Webcast |
|
December 2, 2021Presentation at Stora Aktiedagen Stockholm
| |
|
|
|
December 2, 2021Oasmia - Presentation Erik Penser Bank
| |
|
|
|
November 18, 2021Interim Report January – September 2021
|
|
|
|
|
October 21, 2021Interview Erik Penser Bank
| | |
|
|
September 29, 2021Naventus LifeScience Summit
| |
|
|
|
September 7, 2021Presentation at Aktiedagen Stockholm
| |
|
|
|
August 19, 2021Interim Report January – June 2021
|
|
|
|
|
June 11, 2021Aktiespararna: Interview with Oasmia Pharmaceutical
| | |
|
|
May 27, 2021Interim Report January – March 2021
|
| |
|
|
April 29, 2021Annual Report 2020
|
| | |
|
April 12, 2021Cantrixil abstract from Final Phase I Data at the 2021 AACR Annual Meeting
| |
| |
|
March 21, 2021BioEurope Spring, Virtual
| |
| |
|
March 11, 2021Sachs 14th Annual European Life Sciences CEO Forum, Virtual
| |
| |
|
March 1, 2021Oasmia acquires global development and commercialization rights for Cantrixil
| |
|
|
|
February 19, 2021Year-end report 2020
|
|
|
|
|
January 19, 2021SEB Digital Healthcare Seminar Presentation
| |
| |
